SCN1A and epilepsy: Monogenic epilepsies, such as Dravet Syndrome (SCN1A), provide additional insight into the heterogeneity of SUDEP mechanisms in paediatric epilepsy populations, as well as an opportunity to more precisely identify and treat individuals at increased risk.7–9